| 英文别名 |
Acetamide,N-[6,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6-oxo-1H-purin-2-yl]-;N2-ACETYL-9-[(2'-HYDROXYETHOXY)METHYL]GUANINE;N2-Acetyl Acyclovir;N-[9-(2-hydroxyethoxymethyl)-6-oxo-3H-purin-2-yl]acetamide;N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide;N2-Acetylaciclovir;9-[(2-Hydroxyethoxy)methyl]-N2-acetylguanine;Acyclovir IMpurity F;Acyclovir Related CoMpound F;2-(Acetylamino)-9-(2-hydroxyethoxymethyl)-9H-purine-6(1H)-one;2-(Acetylamino)-9-[(2-hydroxyethoxy)methyl]-9H-purine-6(1H)-one;2-Acetylamino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one;N-[6,9-Dihydro-9-[(2-hydroxyethoxy)Methyl]-6-oxo-1H-purin-2-yl]acetaMide;N2-Acetylacyclovir;Q27278389;Aciclovir EP Impurity F;N-[9-(2-hydroxyethoxymethyl)-6-oxo-1H-purin-2-yl]acetamide;110104-37-5;FT-0642690;Acetamide, N-(6,9-dihydro-9-((2-hydroxyethoxy)methyl)-6-oxo-1H-purin-2-yl)-;N2-ACETYLACICLOVIR [WHO-IP];G007Q63G24;N-{9-[(2-hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl}acetamide;F82761;ACICLOVIR IMPURITY F [WHO-IP];Aciclovir Imp. F (EP); Acyclovir USP Related Compound F; Acyclovir USP RC F; N-[9-[(2-Hydroxyethoxy)-methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide; Acyclovir Related Compound F; Aciclovir Impurity F;DTXSID60149146;AKOS040744770;Aciclovir impurity F [EP];AKOS000656179;EU-0034988;N-(9-((2-Hydroxyethoxy)methyl)-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide;N-[9-[(2-Hydroxyethoxy)-methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide;9-((2-Hydroxyethoxy)methyl)-N2-acetylguanine;UNII-G007Q63G24;ACICLOVIR IMPURITY F [EP IMPURITY];BCP06563;SCHEMBL8444939;TS-08137;Aciclovir Imp. F (EP): N-[9-[(2-Hydroxyethoxy)- methyl]-6-oxo-6,9-dihydro-1H-purin-2- yl]acetamide;Acyclovir Impurity F;Acyclovir Impurity F;CS-0138111;CS-0138111;DB-040896;DB-040896;HY-137362;HY-137362;9-[(2-Hydroxyethoxy)Methyl]-N2-acetylguanine;9-[(2-Hydroxyethoxy)Methyl]-N2-acetylguanine |